← Back to Clinical Trials
Recruiting NCT07316803

NCT07316803 Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07316803
Status Recruiting
Phase
Sponsor Centre hospitalier de Ville-Evrard, France
Condition Severe Mental Illness
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-11-03
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
À deux, c'est mieux (Better Together) Group Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-11-03 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study evaluates a group-based intervention designed to improve romantic and social relationship skills in adults living with a severe mental illness (SMI), such as schizophrenia, bipolar disorder, or major depressive disorder. Many adults with SMI experience loneliness, social isolation, and difficulties forming romantic relationships, even though most express a strong desire for intimacy. These challenges may be related to social skill difficulties, stigma, low self-esteem, and limited opportunities to develop healthy relationships. The "À deux, c'est mieux" (Better Together) program is a structured 12-session group intervention focused on developing communication skills, emotional regulation, social understanding, and healthy romantic relationship behaviors. Sessions are led by trained mental health professionals and take place in small groups. Participants will complete assessments before starting the program, at the end of the 12 sessions, and three months later. The study will examine changes in romantic relationship skills, quality of life, loneliness, self-esteem, self-stigma, and recovery. The purpose of this study is to determine whether this intervention improves romantic and social functioning and overall well-being, and whether it is acceptable and relevant for adults living with severe mental illness.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years and older * Diagnosis of a severe mental illness (e.g., schizophrenia, bipolar disorder, or major depressive disorder) * Currently single * Motivated to improve romantic and social relationships and to pursue a romantic relationship * Received mental health care within the past two years * Able and willing to provide informed consent Exclusion Criteria: * Inability to speak or read French * Currently receiving acute or crisis-level psychiatric care * Unable to comply with study procedures or group rules (e.g., maintaining sobriety during sessions)

Contact & Investigator

Central Contact

Youcef BENCHERIF, Clinical Project Manager

✉ y.bencherif@epsve.fr

📞 00.33.01.43.09.32.32

Principal Investigator

Raluca ROSETTI, Principal Investigator

PRINCIPAL INVESTIGATOR

Psychiatrist, EPS Ville-Evrard

Frequently Asked Questions

Who can join the NCT07316803 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Severe Mental Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07316803 currently recruiting?

Yes, NCT07316803 is actively recruiting participants. Contact the research team at y.bencherif@epsve.fr for enrollment information.

Where is the NCT07316803 trial being conducted?

This trial is being conducted at Épinay-sur-Seine, France, Neuilly-sur-Marne, France.

Who is sponsoring the NCT07316803 clinical trial?

NCT07316803 is sponsored by Centre hospitalier de Ville-Evrard, France. The principal investigator is Raluca ROSETTI, Principal Investigator at Psychiatrist, EPS Ville-Evrard. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology